Log in
NASDAQ:OSUR

OraSure Technologies Stock Forecast, Price & News

$12.33
+0.88 (+7.69 %)
(As of 09/29/2020 12:00 AM ET)
Add
Compare
Today's Range
$11.54
Now: $12.33
$12.47
50-Day Range
$10.23
MA: $12.18
$15.09
52-Week Range
$5.23
Now: $12.33
$19.75
Volume1.42 million shs
Average Volume1.53 million shs
Market Capitalization$882.31 million
P/E RatioN/A
Dividend YieldN/A
Beta0.51
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, OSUR and DNAG. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Its principal products include OraQuick ADVANCE HIV-1/2, OraQuick HIV-1/2, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV, OraQuick Ebola, OraQuick Zika, OraSure QuickFlu Rapid Flu A&B test, OraSure, Oragene DX, Oragene DNA, Oragene RNA, ORAcollect DX, ORAcollect DNA, Performagene, OMNIgene GUT, OMNIgene SPUTUM, OMNIgene VAGINAL, OMNIgene ORAL, GenoFIND, Hemagene, PrepIT, Intercept, MICRO-PLATE DOA assays, Intercept i2, homogeneous DOA assays, and professional and over-the-counter cryosurgical systems. In addition, the company manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. Further, it provides medical devices for the removal of benign skin lesions by cryosurgery or freezing; immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid Western blot confirmatory test for confirming positive HIV-1 test; and Q.E.D. rapid point-of-care saliva alcohol test. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was founded in 2000 and is based in Bethlehem, Pennsylvania.
Read More
OraSure Technologies logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.54 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:OSUR
CUSIP68554V10
Phone610-882-1820

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$154.60 million
Cash Flow$0.27 per share
Book Value$4.98 per share

Profitability

Net Income$16.66 million

Miscellaneous

Employees398
Market Cap$882.31 million
Next Earnings Date11/4/2020 (Estimated)
OptionableOptionable
$12.33
+0.88 (+7.69 %)
(As of 09/29/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OSUR News and Ratings via Email

Sign-up to receive the latest news and ratings for OSUR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











OraSure Technologies (NASDAQ:OSUR) Frequently Asked Questions

How has OraSure Technologies' stock been impacted by Coronavirus?

OraSure Technologies' stock was trading at $5.90 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, OSUR shares have increased by 109.0% and is now trading at $12.33.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of OraSure Technologies?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OraSure Technologies in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for OraSure Technologies
.

When is OraSure Technologies' next earnings date?

OraSure Technologies is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for OraSure Technologies
.

How were OraSure Technologies' earnings last quarter?

OraSure Technologies, Inc. (NASDAQ:OSUR) released its earnings results on Wednesday, August, 5th. The medical instruments supplier reported ($0.16) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.10) by $0.06. The medical instruments supplier had revenue of $29.26 million for the quarter, compared to the consensus estimate of $34.24 million. OraSure Technologies had a negative return on equity of 3.08% and a negative net margin of 1.57%.
View OraSure Technologies' earnings history
.

What price target have analysts set for OSUR?

7 Wall Street analysts have issued 12 month price targets for OraSure Technologies' shares. Their forecasts range from $8.00 to $22.00. On average, they anticipate OraSure Technologies' share price to reach $16.43 in the next twelve months. This suggests a possible upside of 33.2% from the stock's current price.
View analysts' price targets for OraSure Technologies
.

Are investors shorting OraSure Technologies?

OraSure Technologies saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 6,980,000 shares, an increase of 10.8% from the August 15th total of 6,300,000 shares. Based on an average daily trading volume, of 2,180,000 shares, the short-interest ratio is presently 3.2 days.
View OraSure Technologies' Short Interest
.

Who are some of OraSure Technologies' key competitors?

What other stocks do shareholders of OraSure Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OraSure Technologies investors own include Merit Medical Systems (MMSI), Citigroup (C), Energy Transfer LP Unit (ET), XOMA (XOMA), Overstock.com (OSTK), Ford Motor (F), Pfizer (PFE), Abbott Laboratories (ABT), Advanced Micro Devices (AMD) and Activision Blizzard (ATVI).

Who are OraSure Technologies' key executives?

OraSure Technologies' management team includes the following people:
  • Dr. Stephen S. Tang, Pres, CEO & Director (Age 58)
  • Mr. Jack E. Jerrett, Sr. VP, Gen. Counsel & Sec. (Age 60)
  • Mr. Anthony Zezzo II, Exec. VP & Bus. Unit Leader of Infectious Disease (Age 65)
  • Mr. Brian L. Smith, Vice Chairman & EVP of Innovation - DNA Genotek, Inc. (Age 60)
  • Mr. Roberto E. Cuca, CFO & Principal Accounting Officer (Age 51)

What is OraSure Technologies' stock symbol?

OraSure Technologies trades on the NASDAQ under the ticker symbol "OSUR."

How do I buy shares of OraSure Technologies?

Shares of OSUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is OraSure Technologies' stock price today?

One share of OSUR stock can currently be purchased for approximately $12.33.

How big of a company is OraSure Technologies?

OraSure Technologies has a market capitalization of $882.31 million and generates $154.60 million in revenue each year. The medical instruments supplier earns $16.66 million in net income (profit) each year or $0.13 on an earnings per share basis. OraSure Technologies employs 398 workers across the globe.

What is OraSure Technologies' official website?

The official website for OraSure Technologies is www.orasure.com.

How can I contact OraSure Technologies?

OraSure Technologies' mailing address is 220 EAST FIRST STREET, BETHLEHEM PA, 18015. The medical instruments supplier can be reached via phone at 610-882-1820 or via email at [email protected]

This page was last updated on 9/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.